Avenue Therapeutics(DE:49Y)
€0.400.00 (0.00%)
DE:49Y
Avenue Therapeutics earnings date
€0.40
At close:0.00 (0.00%)
Avenue Therapeutics (49Y) Q2 2023 Earnings Report
1 Followers
DE:49Y Q2 2023 EPS Results
- Actual EPS
- -EUR 34.29
- Consensus EPS
- -EUR 19.12
- Beat/Miss
- Missed by -EUR 15.17
- One Year Ago EPS
- -EUR 27.26
DE:49Y Q2 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/10/2023
- Time
- After Close
- Conference Call
- Thursday, August 10, 2023
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:49Y Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 17, 2025 | 2025 (Q3) | ―-0.19 | -1.69 | 88.85% (+1.50) | |
| Aug 18, 2025 | 2025 (Q2) | ―0.09 | -5.65 | 101.63% (+5.75) | |
| May 19, 2025 | 2025 (Q1) | ―-0.55 | -13.54 | 95.95% (+12.99) | |
| Mar 25, 2025 | 2024 (Q4) | -0.50-0.64 | 56.05 | -101.15% (-56.70) | |
| Nov 14, 2024 | 2024 (Q3) | -0.83-1.69 | 3.96 | -142.67% (-5.64) | |
| Aug 09, 2024 | 2024 (Q2) | -0.92-5.65 | -34.29 | 83.51% (+28.64) | |
| May 15, 2024 | 2024 (Q1) | -7.91-13.54 | -90.34 | 85.01% (+76.80) | |
| Mar 18, 2024 | 2023 (Q4) | -6.5956.05 | 8.57 | 553.85% (+47.48) | |
| Nov 13, 2023 | 2023 (Q3) | -17.153.96 | -29.67 | 113.33% (+33.63) | |
| Aug 10, 2023 | 2023 (Q2) | -19.12-34.29 | -27.26 | -25.79% (-7.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

